Skip to Content

Afinitor Sales Data

Rank 97 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Afinitor U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 97 (1) 0.03%
Q3 2013 96 (4) 5.45%
Q2 2013 100 ()

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

September 25, 2015New Immune-Focused Drug Shows Promise Against Advanced Kidney Cancer
September 26, 2011Novartis Drug Afinitor Helps Women With Advanced Breast Cancer Live Significantly Longer Without Their Disease Progressing
May 6, 2011FDA Panel Oks Novartis' Pancreatic Tumor Drug
November 1, 2010Afinitor Approved for Rare Genetic Disorder